Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial) : An Open-Label Randomized Controlled, Multicenter Study
المؤلفون المشاركون
Li, Rui-Jie
Shi, Da-Zhuo
Yang, Guan-Lin
Liu, Hong-Ying
Xu, Hao
Wang, Shao-Li
Mao, Jing-Yuan
Wang, Cheng-Long
Lü, Shu-Zheng
Zhang, Da-Wu
You, Shi-Jie
Chen, Li-Dian
Gao, Zhu-ye
Wang, Pei-Li
Lu, Shu
Zhang, Lei
Du, Jian-Peng
Liu, Hong-Xu
Wang, Xian
Li, Tian-Chang
Chen, Ke-Ji
Ge, Jun-Bo
Fu, Chang-Geng
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2013-07-02
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Aims.
To evaluate the efficacy of Chinese herbal medicines (CHMs) plus conventional treatment in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI).
Methods and Results.
Participants (n=808) with ACS who underwent PCI from thirteen hospitals of mainland China were randomized into two groups: CHMs plus conventional treatment group (treatment group) or conventional treatment alone group (control group).
All participants received conventional treatment, and participants in treatment group additionally received CHMs for six months.
The primary endpoint was the composite of cardiac death, nonfatal recurrent MI, and ischemia-driven revascularization.
Secondary endpoint was the composite of readmission for ACS, stroke, or congestive heart failure.
The safety endpoint involved occurrence of major bleeding events.
The incidence of primary endpoint was 2.7% in treatment group versus 6.2% in control group (HR, 0.43; 95% CI, 0.21 to 0.87; P=0.015).
The incidence of secondary endpoint was 3.5% in treatment group versus 8.7% in control group (HR, 0.39; 95% CI, 0.21 to 0.72; P=0.002).
No major bleeding events were observed in any participant.
Conclusion.
Treatment with CHMs plus conventional treatment further reduced the occurrence of cardiovascular events in patients with ACS after PCI without increasing risk of major bleeding.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Wang, Shao-Li& Wang, Cheng-Long& Wang, Pei-Li& Xu, Hao& Liu, Hong-Ying& Du, Jian-Peng…[et al.]. 2013. Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial) : An Open-Label Randomized Controlled, Multicenter Study. Evidence-Based Complementary and Alternative Medicine،Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-495049
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Wang, Shao-Li…[et al.]. Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial) : An Open-Label Randomized Controlled, Multicenter Study. Evidence-Based Complementary and Alternative Medicine No. 2013 (2013), pp.1-8.
https://search.emarefa.net/detail/BIM-495049
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Wang, Shao-Li& Wang, Cheng-Long& Wang, Pei-Li& Xu, Hao& Liu, Hong-Ying& Du, Jian-Peng…[et al.]. Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial) : An Open-Label Randomized Controlled, Multicenter Study. Evidence-Based Complementary and Alternative Medicine. 2013. Vol. 2013, no. 2013, pp.1-8.
https://search.emarefa.net/detail/BIM-495049
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-495049
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر